Krsnaa Diagnostics

Krsnaa Diagnostics EBITDA per Employee

The EBITDA per Employee of Krsnaa Diagnostics (KRSNAA.NS) as of Nov 5, 2026 is 642,978.14 INR. In the previous year, EBITDA per Employee was 748,610.46 INR — a change of -14.11% (lower).

EBITDA per Employee

642,978.14INR

YoY

-14.11%

Last updated:

EBITDA per Employee of Krsnaa Diagnostics is 2026 642,978.14 INR. EBITDA per Employee of Krsnaa Diagnostics was 2025 748,610.46 INR. It decreases by -14.11% lower compared to the previous year.

The Krsnaa Diagnostics EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
226,081.19 INR
Jan 1, 2020
245,202.97 INR
Jan 1, 2021
368,142.08 INR
Jan 1, 2022
516,366.12 INR
Jan 1, 2023
553,005.46 INR
Jan 1, 2024
568,832.94 INR
Jan 1, 2025
748,610.46 INR
Jan 1, 2026
642,978.14 INR
The Krsnaa Diagnostics EBITDA per Employee history
YEAREBITDA per EmployeeYoY
642,978.14INR-14.11%
748,610.46INR+31.60%
568,832.94INR+2.86%
553,005.46INR+7.10%
516,366.12INR+40.26%
368,142.08INR+50.14%
245,202.97INR+8.46%
226,081.19INR+294.46%
57,314.60INR+215.10%
18,189.62INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

EBITDA per Employee of Krsnaa Diagnostics is 642,978.14 INR in 2026.

EBITDA per Employee of Krsnaa Diagnostics changed from 748,610.46 INR to 642,978.14 INR, representing a -14.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Krsnaa Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Krsnaa Diagnostics

All Key Metrics — Krsnaa Diagnostics